产品目录 Home 主打产品 植物提取物 天然提取物 产品解决方案 联系我们 展会
藤茶提取物二氢杨梅素 Dihydromyricetin
杨梅素 Myricetin
木犀草素Luteolin
苦杏仁甙amygdalin
绿原酸Chlorogenic acid
芹菜素apigenin
厚朴提取物Magnolia bark extract
厚朴酚magnolol
和厚朴酚Honokiol
博落回提取物Macleaya cordata extract
血根碱sanguinarine
白屈菜红碱Chelerythrine
迷迭香提取物rosemary leaf extract
迷迭香酸rosmarnic aicd
鼠尾草酸Carnosic acid
熊果酸Ursolic acid
鼠尾草酸油carnosic acid liquid oil
绿咖啡豆提取物green coffee bean extract
金银花提取物honeysuckle flower extract
巴拿巴叶提取物Banaba leaf extract
枇杷叶提取物Loquat leaf extract
漆黄素Fisetin
虎杖甙Polydatin
芒果甙mangiferin
白桦脂醇Betulin
石杉碱甲huperzine a
阿魏酸Ferulic acid
白藜芦醇Resveratrol

白藜芦醇Resveratrol 

白藜芦醇

品名:白藜芦醇

来源:虎杖

CAS号:501-36-0

分子式:C14H12O3

检测方式: HPLC

 

虎杖是蓼科的植物之一,其原生长于东亚并广泛分布于中国。虎杖在中国和日本传统医药中被用于治疗多种病痛,其中包括霉菌感染,多种皮肤炎症,心血管疾病和肝脏疾病等。 白藜芦醇大黄素是虎杖中的主要功能成分。研究显示白藜芦醇和大黄素表现出广泛的抗氧化特性,如LDL胆固醇氧化和脂质过氧化反应。白藜芦醇同时显示出有助于心血管健康和活血,减轻疼痛,清热去湿,去毒去痰。其它成分包括丹蒽酮大黄素甲醚大黄酸都具有抗炎症,祛关节炎和抗微生物活性。

 

上禾生物专业生产虎杖提取物白藜芦醇,大黄素等。价格优惠,随时发货。产品详询:13657416805

  1. 参考文献:
  2. 1.Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5: 493–506
  3. 2.Bemis DL, Katz AE, Buttyan R (2006) Clinical trials of natural products as chemopreventive agents for prostate cancer. Expert Opin Investig Drugs 15: 1191–200
  4. 3.Aggarwal BB, Bhardwaj A, Aggarwal RS et al. (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24: 2783–2840
  5. 4.Joe AK, Liu H, Suzui M et al. (2002) Resveratrol induces growth inhibition, S phase arrest, apoptosis and changes biomarker expression in several human cancer cell lines. Clin Cancer Res 8: 893–903
  6. 5.Soleas GJ, Grass L, Josephy PD et al. (2006) A comparison of the anticarcinogenic properties of four red wine polyphenols. Clin Biochem 39: 492–497
  7. 6.Providencia R (2006) Cardiovascular protection from alcoholic drinks: scientific basis of the French Paradox. Rev Port Cardiol 25: 1043–1058
  8. 7.Ovesna Z, Kozics K, Bader Y et al. (2006) Antioxidant activity of resveratrol, piceatannol and 3,3’,4,4’,5,5’-hexahydroxy-trans-stilbene in three leukemia cell lines. Oncol Rep 16: 617–624
  9. 8.Athar M, Back JH, Tang X et al. (2007) Resveratrol: A review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol (in press)
  10. 9.Ovesna Z, Horvathova-Kozics K (2005) Structure-activity relationship of trans-resveratrol and its analogues. Neoplasma 52: 450–455
  11. 10.Pezutto JM (2004) Resveratrol: a whiff that induces a biologically specific tsunami. Cancer Biol Ther 3: 889–890
  12. 11.Aziz MH, Nihal M, Fu VX et al. (2006) Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3’-kinase/Akt pathway and Bcl-family proteins. Mol Cancer Ther 5: 1335–1341
  13. 12.Liao Z, Mason KA, Milas L (2007) Cyclo-oxygenase-2 and its inhibition in cancer: is there a role? Drugs 67: 821–845
  14. 13.Horvath Z, Murias M, Saiko P et al. (2006) Cytotoxic and biochemical effects of 3,3’,4,4’,5,5’-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells. Exp Hematol 34: 1377–1384
  15. 14.Murias M, Handler N, Erker T et al. (2004) Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship. Bioorg Med Chem 12: 5571–5578
  16. 15.Benitez DA, Pozo-Guisade E, Alvarez-Barrientos A et al. (2007) Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines. J Androl 28: 282–293
  17. 16.Kampa M, Hatzoglou A, Notas G et al. (2000) Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. Nutr Cancer 37: 23–33

产品目录  |  Home  |  主打产品  |  植物提取物  |  天然提取物  |  产品解决方案  |  联系我们  |  展会  |  网站地图  |  手机版
  English     简体版     繁體版
网站首页联系我们网站地图